would be made aware of it. I wish someone close to them knew of it... and then acted responsibly. Please tell the three sweepers that this was not done in a petri dish.
http://www.ncbi.nlm.nih.gov/pubmed/18036807?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum1: Respir Med. 2008 Mar;102(3):443-8. Epub 2007 Nov 26.Click here to read Links
Therapeutics effect of N-acetyl cysteine on mustard gas exposed patients: evaluating clinical aspect in patients with impaired pulmonary function test.
Shohrati M, Aslani J, Eshraghi M, Alaedini F, Ghanei M.
Research Center of Chemical Injuries, Baqyatallah Medical Sciences University, Mollasadra Street, P.O. Box: 19945-546, Tehran, Iran.
AIMS: Long-term prescription of N-acetyl cysteine (NAC) may be effective in diseases caused by active radicals of oxygen species. The aim of this study was to determine the effect of 2- and 4-month administration of NAC (1800 mg daily) on mustard induced bronchiolitis obliterans.
METHODS AND MATERIALS: In a double blind clinical trial, 144 patients with bronchiolitis obliterans due to sulfur mustard in bronchiolitis obliterans syndrome (BOS) classes 1 and 2, randomly entered Group 1 (n=72, NAC) and Group 2 (n=72, placebo). Dyspnea, wake-up dyspnea, cough, and sputum were measured after 4 months. Spirometric findings were measured at the beginning of the trial, 2 months after and after 4 months of prescription of 1800 mg/day in three doses of NAC or placebo.
RESULTS: Dyspnea, cough, sputum, and wake-up dyspnea improved after 4 months of NAC compared to the control group.
After 4 months, spirometric components were significantly improved in NAC group compared to placebo group. CONCLUSION: Fourth months administration of NAC (1800 mg daily) can improve clinical conditions and spirometric findings in mustard exposed in BOS class 1 or 2.
PMID: 18036807